The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from Business Wire

Incyte to Present at the 32nd Annual Canaccord Genuity Growth Conference

Friday, August 03, 2012

Incyte to Present at the 32nd Annual Canaccord Genuity Growth Conference08:00 EDT Friday, August 03, 2012 WILMINGTON, Del. (Business Wire) -- Incyte Corporation (Nasdaq:INCY) announced today it will present at the 32nd Annual Canaccord Genuity Growth Conference on Wednesday, August 15 at 10:30 a.m. (ET) in Boston. The presentation will be webcast live and can be accessed at under Investor Relations, Events and Webcasts. A replay of the presentation will be available for 90 days. Investors interested in listening to the live webcast should log on before the start time in order to download any software required. Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary small molecule drugs for oncology and inflammation. For additional information on Incyte, please visit the Company's web site at Incyte CorporationPamela M. MurphyVice President, Investor Relations & Corporate Communications302-498-6944